Chapter 13
References
1. Il'yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S, Kritchevsky SB. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2413-8.
2. Wolf I, Sadetzki S, Gluck I, Oberman B, Ben-David M, Papa MZ, Catane R, Kaufman B. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer. 2006 May;42(8):1077-82.
3. Sakr WA, Grignon DJ, Haas GP, Schomer KL, Heilbrun LK, Cassin BJ, Powell J, Montie JA, Pontes JE, Crissman JD. Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract. 1995 Sep;191(9):838-41.
4. Finaud J, Lac G, Filaire E. Oxidative stress : relationship with exercise and training.
Sports Med. 2006;36(4):327-58.
5. Colvin L, Fallon M. Challenges in cancer pain management-bone pain. Eur J Cancer. 2008 May;44(8):1083-1090
6. Segal BH, Freifeld AG, Baden LR, Brown AE, Casper C, Dubberke E, Gelfand M, Greene JN, Ison MG, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marcucci G, Montoya JG, Engemann AM, Rolston K, The AS. Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw. 2008 Feb;6(2):122-74.
7. Vanchieri C. National Cancer Act: a look back and forward. J Natl Cancer Inst. 2007 Mar 7;99(5):342-5.
8. Bendell J, Goldberg RM. Targeted agents in the treatment of pancreatic cancer: history and lessons learned. Curr Opin Oncol. 2007 Jul;19(4):390-5.
9.
Toyokuni S, Okamoto K, Yodoi J, Hiai H.
Persistent oxidative stress in cancer. FEBS Lett. 1995; 358(1):1-3.
10. Galhardo RS, Hastings PJ, Rosenberg SM. Mutation as a stress response and the regulation of evolvability. Crit Rev Biochem Mol Biol. 2007 Sep-Oct;42(5):399-435.
Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications.
Drug Resist Updat.
2004 Apr;7(2):97-110
Piva R, Belardo G, Santoro MG.
NF-kappaB: a stress-regulated switch for cell survival. Antioxid Redox
Signal. 2006 Mar-Apr;8(3-4):478-86.
11. Rosman-Urbach M, Niv Y, Birk Y, Morgenstern S, Schwartz B. Relationship between nutritional habits adopted by ulcerative colitis relevant to cancer development patients at clinical remission stages and molecular-genetic parameters. Br J Nutr. 2006 Jan;95(1):188-95.
12.
Piva R, Belardo G, Santoro MG. NF-kappaB: a stress-regulated switch for cell
survival. Antioxid Redox Signal.
2006 Mar-Apr;8(3-4):478-86.
13. Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy.
Clin J Oncol Nurs. 2007 Dec;11(6):901-13.
14.
Bazakis AM, Kunzler C. Altered
mental status due to metabolic or endocrine disorders.
Emerg Med Clin North Am. 2005 Aug;23(3):901-8, x-xi.
15.
Geissbuhler P.
Mermillod B.
Rapin CH.
Elevated serum vitamin B12 levels associated with CRP as a predictive
factor of mortality in palliative care cancer patients: a prospective study over
five years. Journal of Pain & Symptom Management. 20(2):93-103, 2000
16. McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008 May 1:1-6.
17. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):279-86.
18. Lindskog M, Gleissman H, Ponthan F, Castro J, Kogner P, Johnsen JI. Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress. Int J Cancer. 2006 May 15;118(10):2584-93.
19.
Whitten DL, Myers SP, Hawrelak JA, Wohlmuth H. The effect of
Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst. 2002 Aug 21;94(16):1247-9.
Block KI, Gyllenhaal C. Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes. Integr Cancer Ther. 2002 Mar;1(1):83-9.
20. Samuels N. Herbal remedies and anticoagulant therapy. Thromb Haemost. 2005 Jan;93(1):3-7.
21. Genser D. Food and drug interaction: consequences for the nutrition/health status. Ann Nutr Metab. 2008;52 Suppl 1:29-32.
22. Clayton NP, Yoshizawa K, Kissling GE, Burka LT, Chan PC, Nyska A. Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract. Exp Toxicol Pathol. 2007 Jan;58(4):223-36.
Mahady GB, Dog TL, Barrett ML, Chavez ML, Gardiner P, Ko R, Marles RJ, Pellicore LS, Giancaspro GI, Sarma DN. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause. 2008 Mar 12. [Epub ahead of print]
23. Kumar NB, Allen K, Bell H. Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening. Cancer Control. 2005 Jul;12(3):149-57.